학술논문
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Document Type
Journal Article
Author
Kohei Shitara; Ӧzgϋroǧlu, Mustafa; Yung-Jue Bang; Di Bartolomeo, Maria; Mandalà, Mario; Min-Hee Ryu; Fornaro, Lorenzo; Olesiński, Tomasz; Caglevic, Christian; Chung, Hyun C.; Kei Muro; Goekkurt, Eray; Mansoor, Wasat; McDermott, Raymond S.; Shacham-Shmueli, Einat; Xinqun Chen; Mayo, Carlos; Kang, S. Peter; Atsushi Ohitsu; Fuchs, Charles S.
Source
Subject
*STOMACH cancer treatment
*PEMBROLIZUMAB
*PACLITAXEL
*CANCER chemotherapy
*RANDOMIZED controlled trials
*THERAPEUTICS
*THERAPEUTIC use of monoclonal antibodies
*ADENOCARCINOMA
*COMPARATIVE studies
*ESOPHAGUS
*ESOPHAGEAL tumors
*INTRAVENOUS therapy
*RESEARCH methodology
*MEDICAL cooperation
*MONOCLONAL antibodies
*RESEARCH
*STATISTICAL sampling
*STOMACH tumors
*SURVIVAL
*TUMOR classification
*EVALUATION research
*TREATMENT effectiveness
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0140-6736
Abstract